Clincosm LogoSign in Get a demo

Prostate Adenocarcinoma

Showing NaN - NaN of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Los Angeles (drug,

Not yet recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 5, 2023

Prostate Adenocarcinoma Trial in United States (procedure, drug, dietary supplement)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Biopsy
  • +3 more
  • Los Angeles, California
  • +4 more
Sep 7, 2023

Prostate Adenocarcinoma Trial in Duarte, Los Angeles, Durham (Fasting Mimicking Diet (FMD), Usual Diet)

Not yet recruiting
  • Prostate Adenocarcinoma
  • Fasting Mimicking Diet (FMD)
  • Usual Diet
  • Duarte, California
  • +2 more
Apr 27, 2023

Prostate Cancer, Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in United States (Exercise Therapy)

Recruiting
  • Prostate Cancer
  • +2 more
  • Exercise Therapy
  • Los Angeles, California
  • +7 more
Feb 20, 2023

Work Experience in Patients With Stage I-III Prostate Cancer

Recruiting
  • Prostate Adenocarcinoma
  • +3 more
  • Interview
  • Questionnaire Administration
  • Phoenix, Arizona
  • +324 more
Dec 21, 2022

Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8

Recruiting
  • Prostate Adenocarcinoma
  • +5 more
  • Discussion
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 1, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC

Recruiting
  • Prostate Adenocarcinoma
  • +7 more
  • High-Dose Rate Brachytherapy
  • Stereotactic Body Radiation Therapy
  • Los Angeles, California
    University of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022

Prostate Adenocarcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in United States

Recruiting
  • Prostate Adenocarcinoma
  • +6 more
  • Gonadotrophin Releasing Hormone
  • +2 more
  • Gilbert, Arizona
  • +86 more
Sep 27, 2022

Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma, Recurrent Prostate Adenocarcinoma Trial in Los Angeles (drug,

Not yet recruiting
  • Oligometastatic Prostate Carcinoma
  • +3 more
  • Lutetium Lu-177 PNT2002
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Aug 15, 2022

Localized Prostate Carcinoma, Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8 Trial in United States (Apalutamide,

Recruiting
  • Localized Prostate Carcinoma
  • +8 more
  • Tucson, Arizona
  • +4 more
Jun 28, 2022

Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma, Stage II Prostate Adenocarcinoma Trial in Canada, Switzerland, United

Active, not recruiting
Has Results
  • Prostate Adenocarcinoma
  • +3 more
  • Hypofractionated radiation therapy
  • +2 more
  • Birmingham, Alabama
  • +240 more
Jun 6, 2022

CT-guided Stereotactic Body Radiation Therapy and MRI-guided

Active, not recruiting
  • Prostate Adenocarcinoma
  • CT-guided Stereotactic Body Radiation Therapy
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 3, 2022

Hemi-Gland Cryoablation for Prostate Cancer at UCLA

Enrolling by invitation
  • Prostate Cancer
  • +2 more
  • Hemigland Cryoablation
  • Los Angeles, California
    University of California, Los Angeles
Jan 25, 2022

Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Los Angeles

Completed
  • Biochemically Recurrent Prostate Carcinoma
  • +8 more
  • Computed Tomography
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Sep 29, 2021

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in Los Angeles (Computed

Completed
  • Prostate Adenocarcinoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jul 1, 2021

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Los Angeles (radiation, other, procedure)

Completed
  • Prostate Adenocarcinoma
  • Recurrent Prostate Carcinoma
  • Gallium Ga 68 Gozetotide
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Jun 30, 2021

Prostate Cancer, Prostate Adenocarcinoma, Prostate Cancer Recurrent Trial in Canada, United States (18F-DCFPyL, PET/CT Imaging)

Completed
Has Results
  • Prostate Cancer
  • +3 more
  • Duarte, California
  • +13 more
Jun 10, 2021

Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer

Terminated
  • Hormone-Resistant Prostate Cancer
  • +2 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Los Angeles, California
  • +2 more
Apr 1, 2021

Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage II Prostate Cancer AJCC v8

Withdrawn
  • Prostate Adenocarcinoma
  • +5 more
  • High-Dose Rate Brachytherapy
  • +3 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Nov 4, 2020

Drug Resistance in Metastatic Castration-Resistant Prostate

Completed
  • Castration Levels of Testosterone
  • +5 more
  • Cytology Specimen Collection Procedure
  • +2 more
  • Los Angeles, California
  • +2 more
Sep 24, 2020

Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Canada, United States (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Fairbanks, Alaska
  • +169 more
Feb 23, 2018

Prostate Adenocarcinoma, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial in United States (drug, other, procedure)

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Los Angeles, California
  • +14 more
Sep 18, 2017

Prostate Adenocarcinoma Trial in Los Angeles (Estramustine, Docetaxel, Carboplatin)

Completed
  • Prostate Adenocarcinoma
  • Los Angeles, California
    Norris Comprehensive Cancer Center
May 20, 2014